Cambridge university hospital

Cambridge CB2 0QQ

1 studies enrolling now · 11 studies all time

What they study most

Acute Ischemic Stroke, Advanced Solid Tumors, Breast Cancer, Chronic Lymphoproliferative Diseases (CLPD), Congenital Thrombotic Thrombocytopenic Purpura, JIA, Low Grade Serous Ovarian Cancer, Metastatic Breast Cancer, Metastatic Castration-Resistant Prostate Cancer, Non Alcoholic Steatohepatitis (NASH), Non-small Cell Lung Cancer, Plasma Cell Disorder

Studies at this site

• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) — Running, not enrolling
• Study to Evaluate CCS1477 in Advanced Tumours — Completed
• Adalimumab in JIA-associated Uveitis Stopping Trial — Completed
• Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
• Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer — Completed
• Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer — Completed
• Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP] — Completed
• Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients — Completed